Institutional Ownership
Matinas Biopharma Hldgs Inc
CUSIP 576810303COM NEWMTNBQ1 2026
13D / 13G Filings
11
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
24.1%
Max % of class reported
Institutional Holders
25
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
11 filings · latest Nov 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2025 | Highbridge Capital Management, LLC | 13G/A | — | 49 | SEC |
| 2 | Sep 25, 2025 | Hezbay Holdings LLC | 13D/A | 5.0% | — | SEC |
| 3 | Aug 19, 2025 | Lazar David E. | 13G | 9.8% | 545.0K | SEC |
| 4 | Aug 14, 2025 | Highbridge Capital Management, LLC | 13G/A | 8.4% | 466.7K | SEC |
| 5 | Apr 10, 2025 | Sanitam Partners LLC | 13D/A | 10.0% | — | SEC |
| 6 | Apr 10, 2025 | Pembroke &Amp; Partners LLC | 13D/A | 10.0% | — | SEC |
| 7 | Feb 21, 2025 | Pembroke &Amp; Partners LLC | 13D | 20.0% | — | SEC |
| 8 | Feb 21, 2025 | Sanitam Partners LLC | 13D | 24.1% | — | SEC |
| 9 | Feb 19, 2025 | Chaim Herzog | 13D/A | 3.6% | — | SEC |
| 10 | Jan 6, 2025 | Chaim Herzog | 13D | 5.2% | — | SEC |
1 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Matinas Biopharma Hldgs Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 65.2K | $32.6K |
| 2 | Citadel Advisors LLC | 51.7K | $25.8K |
| 3 | Blackrock, Inc. | 49.6K | $24.8K |
| 4 | Holos Integrated Wealth LLC | 32.5K | $16.3K |
| 5 | Renaissance Technologies LLC | 28.6K | $14.3K |
| 6 | Xtx Topco Ltd | 20.7K | $10.4K |
| 7 | State Street Corp | 15.3K | $7.7K |
| 8 | Susquehanna International Group, LLP | 14.3K | $7.2K |
| 9 | Sargent Investment Group, LLC | 12.7K | $6.4K |
| 10 | Tower Research Capital LLC (Trc) | 2.9K | $1.4K |